Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Melasma
Interventions
DRUG

Glycolic Acid 70%

Group A: contain 27 patients which had been treated every 2 weeks for 12 weeks with 70% glycolic acid to assess chemical peeling and cold water was used for washing

DRUG

Tranexamic acid injection

Group B: contain 27 patients treated with an intradermal injection of 0.05 mL of tranexamic acid solution in normal saline (4 mg/mL) into the melasma lesion at 1 cm distance using a sterile insulin syringe, weekly for 12 weeks

Trial Locations (1)

Unknown

Combined military hospital, Abbottābād

All Listed Sponsors
lead

Combined Military Hospital Abbottabad

OTHER